Association of PLA2G2A single nucleotide polymorphism and cardiometabolic diseases in an HIV-infected population

Elvis Ngwa Ndonwi1,2, Unati Nqebelele3, Tandi Edith Matsha1,4

  • 1South African Medical Research Council/Cape Peninsula University of Technology, Cardiometabolic Health Research Unit, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town, Western Cape 7535, South Africa.

Biomedical Reports
|December 8, 2025
PubMed

Insights

Single nucleotide polymorphisms in the phospholipase A2 (PLA2) gene are linked to cardiometabolic diseases (CMDs). This study explored PLA2 gene SNPs and CMDs in South African HIV-infected individuals, finding potential utility for PLA2G2A in risk assessment.

Area of Science:

  • Genetics and Genomics
  • Cardiology
  • Infectious Diseases

Background:

  • Single nucleotide polymorphisms (SNPs) in the phospholipase A2 (PLA2) gene are associated with cardiometabolic diseases (CMDs).
  • Associations between PLA2 gene SNPs and CMDs have not been established in HIV-infected African populations.
  • This study investigated these associations in a South African HIV-infected cohort.

Purpose of the Study:

  • To investigate the association between PLA2 gene single nucleotide polymorphisms (SNPs) and cardiometabolic diseases (CMDs) in a South African human immunodeficiency virus (HIV)-infected population.

Main Methods:

  • Cross-sectional study of 716 HIV-infected participants from Cape Town, South Africa.
  • Assessment of Hardy-Weinberg equilibrium (HWE) for investigated SNPs.
  • Comparison of CMDs across genotypes using linear and logistic regression, adjusted for age and sex.

Main Results:

  • SNP rs4744 genotypes (GG dominant, AA recessive) were in HWE.
  • The rs4744 dominant genotype was associated with higher high-density lipoprotein-cholesterol (HDL-C) and BMI ≥30 kg/m².
  • The rs4744 recessive genotype was linked to dyslipidemia (low HDL-C) and metabolic syndrome (MetS).

Conclusions:

  • The phospholipase A2 group IIA (PLA2G2A) gene shows potential utility for assessing cardiometabolic disease risk.
  • This is particularly relevant for African individuals living with HIV.
  • PLA2G2A may serve as a biomarker for CMD risk stratification in this population.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
521